Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria

Abstract

H1 nonsedating antihistamines, such as desloratadine, are first-line treatment options for chronic spontaneous urticaria (CSU). However, desloratadine induces various degrees of sedation side effect in CSU patients, and no biomarkers currently exist for predicting the severity of such side effect. Herein, we evaluated the association between HRH1 gene rs901865 polymorphism and the severity of sedation side effect following desloratadine therapy in patients with CSU. We found that 20 of the 114 patients (17.50%) showed sedation side effect after desloratadine treatment, and 3 patients (2.63%) experienced serious sleepiness. The frequency of HRH1 rs901865 G allele was significantly higher in patients who experienced sedation than in patients with rs901865 A allele (pā€‰=ā€‰0.0009). Moreover, patients with the rs901865 G/G genotype suffered a more serious sedation side effect than patients with the rs901865 G/A genotype (pā€‰=ā€‰0.005). These results provide evidence that the HRH1 rs901865 G/G polymorphism is associated with severe sedation side effect after desloratadine treatment. Thus, the HRH1 rs901865 allele may potentially be used as a biomarker for predicting the severity of sedation side effect in patients suffering from CSU and treated with desloratadine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Maurer M, Weller K, BindslevJensen C, GimĆ©nez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy. 2011;66:317ā€“30.

    ArticleĀ  CASĀ  Google ScholarĀ 

  2. Rabelo-FR Daltro-OR, Campos RA. Parameters associated with chronic spontaneous urticaria duration and severity: a systematic review. Int Arch Allergy Immunol. 2013;161:197ā€“204.

    ArticleĀ  Google ScholarĀ 

  3. Dressler C, Rosumeck S, Werner RN, Magerl M, Metz M, Maurer M, et al. Executive summary of the methods report for The EAACI/GA2 LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. Allergy. 2018;73:1145ā€“6.

    ArticleĀ  CASĀ  Google ScholarĀ 

  4. Izumi N, Mizuguchi H, Umehara H, Ogino S, Fukui H. Evaluation of efficacy and sedative profiles of H1 antihistamines by large-scale surveillance using the visual analogue scale (VAS). Allergol Int. 2008;57:257ā€“63.

    ArticleĀ  Google ScholarĀ 

  5. Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW, et al. Central nervous system side effects of first-and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics. 2004;113:116ā€“21.

    ArticleĀ  Google ScholarĀ 

  6. Snidvongs K, Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W. Sedative effects of levocetirizine: a systematic review and meta-analysis of randomized controlled studies. Drugs 2017;77:175ā€“86.

    ArticleĀ  CASĀ  Google ScholarĀ 

  7. Kreutner W, Hey JA, Chiu P, Barnett A. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects. Arzneimittelforschung. 2000;50:441ā€“8.

    CASĀ  PubMedĀ  Google ScholarĀ 

  8. Johannes R, Ruƈ, Anke G, Edwin B, Miller Bruce. Pharmacology and therapeutics. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol. 2001;40:72ā€“6.

    ArticleĀ  Google ScholarĀ 

  9. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672ā€“9.

    ArticleĀ  CASĀ  Google ScholarĀ 

  10. Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, et al. Bilastine International Working Group. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients. Allergy. 2009;64:158ā€“65.

    ArticleĀ  CASĀ  Google ScholarĀ 

  11. Maciel-Guerra H, Penha MƁ, Jorge MFS, LibĆ³rio RDS, Carrijo ACNDA, Parise-Fortes MR, et al. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil. Bras Dermatol. 2018;93:233ā€“7.

    ArticleĀ  Google ScholarĀ 

  12. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharm Rev. 1997;49:253ā€“8.

    CASĀ  PubMedĀ  Google ScholarĀ 

  13. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88:1183ā€“241.

    ArticleĀ  CASĀ  Google ScholarĀ 

  14. Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011;475:65ā€“70.

    ArticleĀ  CASĀ  Google ScholarĀ 

  15. Panula P, Nuutinen S. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci. 2013;14:472ā€“87.

    ArticleĀ  CASĀ  Google ScholarĀ 

  16. Panula P, Wasowicz K. Action of antiulcer drugs. Science. 1993;262:1454ā€“5.

    ArticleĀ  CASĀ  Google ScholarĀ 

  17. Chen C, Hanson E, Watson JW, Lee JS. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists. Drug Metab Dispos. 2003;31:312ā€“8.

    ArticleĀ  CASĀ  Google ScholarĀ 

  18. Baroody F, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM, et al. The effects of H1 antihistamines on the early allergic response. Ann Allergy. 1989;63:551ā€“5.

    CASĀ  PubMedĀ  Google ScholarĀ 

  19. Parmentier R, Zhao Y, Perier M, Akaoka H, Lintunen M, Hou Y, et al. Role of histamine H1-receptor on behavioral states and wake maintenance during deficiency of a brain activating system: a study using a knockout mouse model. Neuropharmacology. 2016;106:20ā€“34.

    ArticleĀ  CASĀ  Google ScholarĀ 

  20. Tiwari AK, Zhang D, Pouget JG, Zai CC, Chowdhury NI, Brandl EJ, et al. Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain. World J Biol Psychiatry. 2016;15:1ā€“9.

    ArticleĀ  Google ScholarĀ 

  21. Anvari S, Vyhlidal CA, Dai H, Jones BL. Genetic variation along the histamine pathway in children with allergic versus nonallergic asthma. Am J Respir Cell Mol Biol. 2015;53:802ā€“9.

    ArticleĀ  CASĀ  Google ScholarĀ 

  22. Raje N1, Vyhlidal CA, Dai H, Jones BL. Genetic variation within the histamine pathway among patients with asthma-a pilot study. J Asthma. 2015;52:353ā€“62.

    ArticleĀ  CASĀ  Google ScholarĀ 

  23. Li P, Wei MJ, Zhang ZY, Yin SJ, Wang X, Lou YQ, et al. Effects of UGT1A1, CYP3A5 and ABCB1 genetic variants on pharmacokinetics of antihistamine drug mizolastine in chinese healthy volunteers. Basic Clin Pharm Toxicol. 2018;123:464ā€“73.

    ArticleĀ  CASĀ  Google ScholarĀ 

  24. Yan S, Chen W, Wen S, Zhu W, Guo A, Chen X, et al. Influence of component 5a receptor 1 (C5AR1)-1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria. J Dermatol Sci. 2014;76:240ā€“5.

    ArticleĀ  CASĀ  Google ScholarĀ 

  25. Guo A, Zhu W, Zhang C, Wen S, Chen X, Chen M, et al. Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients. Arch Dermatol Res. 2015;307:183ā€“90.

    ArticleĀ  CASĀ  Google ScholarĀ 

  26. Li J, Guo A, Chen W, Bin L, He Y, Zhu W, et al. Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine. J Allergy Clin Immunol. 2017;139:1386ā€“8.

    ArticleĀ  CASĀ  Google ScholarĀ 

  27. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. Neurosci. 2002;22:7695ā€“711.

    ArticleĀ  CASĀ  Google ScholarĀ 

  28. Zhou MH, Zheng H, Si H, Jin Y, Peng JM, He L, et al. Stromal interaction molecule 1 (STIM1) and Orai1 mediate histamine-evoked calcium entry and nuclear factor of activated T-cells (NFAT) signaling in human umbilical vein endothelial cells. J Biol Chem. 2014;17:29446ā€“56. 289

    ArticleĀ  Google ScholarĀ 

  29. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540ā€“5.

    ArticleĀ  Google ScholarĀ 

  30. Wright C, Shin JH, Rajpurohit A, Deep-Soboslay A, Collado-Torres L, Brandon NJ, et al. Altered expression of histamine signaling genes in autism spectrum disorder. Transl Psychiatry 2017;9:e1126.

    ArticleĀ  Google ScholarĀ 

  31. Solismaa A, Kampman O, LyytikƤinen LP, SeppƤlƤ N4, Viikki M, Mononen N, et al. Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients. Eur Neuropsychopharmacol. 2017;27:442ā€“9.

    ArticleĀ  CASĀ  Google ScholarĀ 

  32. Vehof J, Risselada AJ, Al Hadithy AF, Burger H, Snieder H, Wilffert B, et al. Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication. Psychopharmacology. 2011;216:257ā€“65.

    ArticleĀ  CASĀ  Google ScholarĀ 

  33. Godlewska BR, Olajossy-Hilkesberger L, Olajossy M, Limon J, Landowski J. Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain. J Clin Psychopharmacol. 2013;33:436ā€“7.

    ArticleĀ  Google ScholarĀ 

Download references

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (grant Nos. 81430075 and 81225013 to Chen X.; grant No. 81673065 to Jie Li), Science and Technology Project of Hunan Province (2014SK3108 to Jie Li), Science and Technology Committee of Haidian District (C4WNX-001 to Juan Li).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jie Li or Xiang Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisherā€™s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Chen, W., Peng, C. et al. Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria. Pharmacogenomics J 20, 87ā€“93 (2020). https://doi.org/10.1038/s41397-019-0094-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41397-019-0094-0

Search

Quick links